Modulation of cAMP-mediated vasorelaxation by endothelial nitric oxide and basal cGMP in vascular smooth muscle

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 4, 1998, Pages 543-551

  Toyoshima, Hiroko ^a   Nasa, Yoshihisa ^a   Hashizume, Yoko ^a   Koseki, Yumi ^a   Isayama, Yoko ^a   Kohsaka, Yumi ^a   Yamada, Tomoko ^a   Takeo, Satoshi ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Cyclic AMP; Cyclic GMP; Endothelial nitric oxide; Isoproterenol; Rat pulmonary artery; Rat thoracic aorta

Indexed keywords

ACETYLCHOLINE; BUCLADESINE; CYCLIC AMP; CYCLIC GMP; DENOPAMINE; FORSKOLIN; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE; SALBUTAMOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; SECOND MESSENGER; SIGNAL TRANSDUCTION; TISSUE LEVEL; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADRENERGIC BETA-AGONISTS; ANIMALS; CYCLIC AMP; CYCLIC GMP; DRUG INTERACTIONS; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; ISOPROTERENOL; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PULMONARY ARTERY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; THORACIC ARTERIES; VASODILATION;

EID: 0031683184     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199810000-00006     Document Type: Article

References (43)

1. Lincoln TM. Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 1989;41:479-502.
2. Murray KJ. Cyclic AMP and mechanisms of vasodilation. Pharmacol Ther 1990;47:329-45.
3. Krauss SL, Dodge JT, Bevan JA. Magnitude of β-adrenoceptor-mediated responses of dog epicardial coronary arteries: inverse relation to diameter. Am J Physiol 1992;263:H1422-9.
4. Bea ML, Ghaleh B, Giudicelli JF, Berdeaux A. Lack of importance of NO in β-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries. Br J Pharmacol 1994;111:981-2.
5. Rubanyi G, Vanhoune PM. Endothelium-removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine. J Cardiovasc Pharmacol 1985;7:139-44.
6. D'Orleans-Juste P, Dion S, Mizrahi J, Regoli D. Effects of peptides and non-peptides on isolated arterial smooth muscles: role of endothelium. Eur J Pharmacol 1985;114:9-21.
7. Gray DW, Marshall I. Novel signal transduction pathway mediating endothelium-dependent β-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol 1992;107:684-90.
8. Grace GC, Macdonald PS, Dusting GJ. Cyclic nucleotide interactions involved in endothelium-dependent dilatation in rat aortic rings. Eur J Pharmacol 1988;148:17-24.
9. Kamata K, Miyata N, Kasuya Y. Involvement of endothelial cells in relaxation and contraction responses of the aorta to isoproterenol in naive and streptozotocin-induced diabetic rats. J Pharmacol Exp Ther 1989;249:890-4.
10. Delpy E, Coste H, le Monnier de Gouville AC. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3. Br J Pharmacol 1996;119:471-8.
11. Moncada S, Rees DD, Schulz R, Palmer RMJ. Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci U S A 1991;88:2166-70.
12. Eckly AE, Stoclet JC, Lugnier C. Isoprenaline induces endothelium-independent relaxation and accumulation of cyclic nucleotides in the rat aorta. Eur J Pharmacol 1994;271:237-40.
13. 2-adrenoceptor activation in rat aortic rings. Br J Pharmacol 1996;119:505-10.
14. Arribas S, Marin J, Ponte A, Balfagon G, Salaices M. Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors: impairment by ageing and hypertension. J Pharmacol Exp Ther 1994;270:520-7.
15. Parent R, Al-Obaidi M, Lavallee M. Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res 1993;73:241-51.
16. Ghaleh B, Bea M-L, Dubois-Rande J-L, Giudicelli J-F, Hittinger L, Berdeaux A. Endothelial modulation of β-adrenergic dilation of large coronary arteries in conscious dogs. Circulation 1995;92:2627-35.
17. Dawes M, Chowienczyk PJ, Ritter JM. Effects of inhibition of the L-arginine/nitric oxide pathway on vasodilation caused by β-adrenergic agonists in human forearm. Circulation 1997;95:2293-7.
18. Rebich S, Devine JO, Armstead WM. Role of nitric oxide and cAMP in β-adrenoceptor-induced pial artery vasodilation. Am J Physiol 1995;268:H1071-6.
19. 2+-dependent intracellular signalling mechanisms in brain capillary endothelial cells. J Neurochem 1994;62:2269-74.
20. Goldberg ND, Haddox MK, Nichol SE, et al. Biological regulation through opposing influences of cyclic GMP and cyclic AMP: the yinyang hypothesis. Adv Cyclic Nucleotide Res 1975;5:307-30.
21. Maurice DH, Crankshaw D, Haslam RJ. Synergistic actions of nitrovasodilators and isoprenaline on rat aortic smooth muscle. Eur J Pharmacol 1991;192:235-42.
22. de Wit C, von Bismarck P, Poh U. Synergistic action of vasodilators that increase cGMP and cAMP in the hamster cremaster microcirculation. Cardiovasc Res 1994;28:1513-8.
23. Manganiello VC, Murata T, Taira M, Beifrage P, Degerman E. Diversity in cyclic nucleotide phosphodiesterase isoenzyme families. Arch Biochem Biophys 1995;322:1-13.
24. Nasa Y, Toyoshima H, Ohaku H, Hashizume Y, Sanbe A, Takeo S. Impairment of cGMP- and cAMP-mediated vasorelaxations in rats with chronic heart failure. Am J Physiol 1996;271:H2228-37.
25. Shafiq J, Suzuki S, Itoh T, Kuriyama H. Mechanism of vasodilation induced by NKH477, a water-soluble forskolin derivative, in smooth muscle of the porcine coronary artery. Circ Res 1992;71:70-81.
26. G-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br J Pharmacol 1990; 99:408-12.
27. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75.
28. 2-adrenoceptor mediate smooth muscle relaxation in bovine isolated mesenteric lymphatics. J Pharmacol Exp Ther 1991;259:365-70.
29. Moncada S, Palmer RMJ, Higgs E. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-12.
30. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
31. Howell RE, Albelda SM, Daise ML, Levine EM. Characterization of β-adrenergic receptors in cultured human and bovine endothelial cells. J Appl Physiol 1988;65:1251-7.
32. Wang YX, Poon KS, Randall DJ, Pang CCY. Endothelium-derived nitric oxide partially mediates salbutamol-induced vasodilatations. Eur J Pharmacol 1993;250:335-40.
33. Graves J, Poston L. β-Adrenoceptor agonist mediated relaxation of rat isolated resistance arteries: a role for the endothelium and nitric oxide. Br J Pharmacol 1993;108:631-7.
34. Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. Biochem Pharmacol 1987;36:3965-72.
35. Linz W, Wiemer G, Scholkens BA. Effects of colforsin, trequinsin and isoprenaline on norepinephrine-induced contractions and cyclic nucleotide levels of isolated vascular tissue. Arzneimittelforschung Drug Res 1988;38:240-3.
36. 2+ by cAMP in vascular smooth muscle cells. Am J Physiol 1990;258:0399-407.
37. Jiang H, Colbran JL, Francis SH, Corbin JD. Direct evidence for cross-activation of cGMP-dependent protein kinase by cAMP in pig coronary arteries. J Biol Chem 1992;267:1015-9.
38. Graier WF, Groschner K, Schmidt K, Kukovetz WR. Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF). Biochem J 1992;288: 345-9.
39. Wright IK, Amirchetty-Rao S, Kendall DA. Potentiation by forskolin of both SNP- and ANP-stimulated cyclic GMP accumulation in porcine isolated palmar lateral vein. Br J Pharmacol 1994; 112:1146-50.
40. Weigert AL, Schini VB, Bond R, Vanhoutte PM. Basal release of nitric oxide modulates the relaxing effect of isoproterenol (ISO) in the aorta of the rat. FASEB J 1992;6:A1509.
41. Rose RJ, Liu H, Palmer D, Maurice DH. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity. Br J Pharmacol 1997;122:233-40.
42. Eckly AE, Lugnier C. Role of phosphodiesterase III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Br J Pharmacol 1994;113:445-50.
43. Shaul PW, Muntz KH, Buja LM. Comparison of beta adrenergic receptor binding characteristics and coupling to adenylate cyclase in rat pulmonary artery versus aorta. J Pharmacol Exp Ther 1990; 252:86-92.